If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...
Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...
Mathematical modeling from U-M could help better optimize dosing regimens for patients with Parkinson's disease, depression and more Study ...
Discover the impact of dopamine on the brain's reward circuit, from pleasure to addiction, and how to find balance.
14don MSN
Mathematical model could help boost drug efficacy by getting dosing in rhythm with circadian clocks
Researchers at the University of Michigan have developed a mathematical model that reveals how our circadian rhythms can have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback